| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
143,520,000 |
| Market
Cap: |
63.51(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.4425 - $0.4425 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile EyePoint Pharmaceuticals is a pharmaceutical company focused on developing and commercializing therapeutics for patients with eye disorders. Co.'s primary product candidate, EYP-19, is a potential sustained delivery intravitreal anti-VEGF treatment targeting wet age-related macular degeneration. YUTIQ 50 (fluocinolone acetonide intravitreal implant) 0.18 mg for intravitreal injection, is for the treatment of non-infectious uveitis affecting the posterior segment of the eye. DEXYCU® (dexamethasone intraocular suspension) 9%, for intraocular administration, is indicated for the treatment of post-operative ocular inflammation.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
20,000 |
4,837,297 |
| Total Buy Value |
$0 |
$0 |
$113,450 |
$89,794,363 |
| Total People Bought |
0 |
0 |
1 |
5 |
| Total Buy Transactions |
0 |
0 |
4 |
14 |
| Total Shares Sold |
2,722 |
2,722 |
2,722 |
6,199,096 |
| Total Sell Value |
$31,602 |
$31,602 |
$31,602 |
$121,681,760 |
| Total People Sold |
1 |
1 |
1 |
8 |
| Total Sell Transactions |
1 |
1 |
1 |
28 |
| End Date |
2025-08-24 |
2025-05-23 |
2024-11-22 |
2023-11-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ribeiro Ramiro |
Chief Medical Officer |
• – – |
2025-11-11 |
4 |
S |
$11.61 |
$31,602 |
D/D |
(2,722) |
0 |
|
- |
|
| Elston George |
Chief Financial Officer |
• – – |
2025-09-19 |
4 |
GA |
$0.00 |
$0 |
I/I |
20,000 |
20,000 |
|
- |
|
| Elston George |
Chief Financial Officer |
• – – |
2025-09-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
62,114 |
|
- |
|
| Zaderej Karen L. |
|
– • – |
2025-07-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,000 |
38,500 |
|
- |
|
| Duker Jay S. |
President and CEO |
• • – |
2025-07-10 |
4 |
D |
$11.06 |
$85,029 |
D/D |
(7,688) |
9,965 |
|
- |
|
| Duker Jay S. |
President and CEO |
• • – |
2025-07-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,667 |
17,653 |
|
- |
|
| Lurker Nancy |
|
– • – |
2025-07-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,111 |
216,547 |
|
- |
|
| Duker Jay S. |
President and CEO |
• • – |
2025-06-23 |
4 |
D |
$8.21 |
$465,220 |
D/D |
(56,665) |
986 |
|
- |
|
| Elston George |
Chief Financial Officer |
• – – |
2025-05-25 |
4 |
D |
$5.68 |
$12,507 |
D/D |
(2,202) |
80,848 |
|
- |
|
| Elston George |
Chief Financial Officer |
• – – |
2025-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
83,050 |
|
- |
|
| Zaderej Karen L. |
|
– • – |
2025-05-19 |
4 |
B |
$5.99 |
$29,950 |
D/D |
5,000 |
36,500 |
0.01 |
- |
|
| Zaderej Karen L. |
|
– • – |
2025-05-16 |
4 |
B |
$5.81 |
$29,050 |
D/D |
5,000 |
31,500 |
0.01 |
- |
|
| Zaderej Karen L. |
|
– • – |
2025-05-15 |
4 |
B |
$5.47 |
$27,350 |
D/D |
5,000 |
26,500 |
0.01 |
- |
|
| Zaderej Karen L. |
|
– • – |
2025-05-14 |
4 |
B |
$5.42 |
$27,100 |
D/D |
5,000 |
21,500 |
0.01 |
- |
|
| Duker Jay S. |
President and CEO |
• • – |
2025-03-19 |
4 |
D |
$6.16 |
$123,100 |
D/D |
(20,000) |
57,651 |
|
- |
|
| Lurker Nancy |
|
– • – |
2025-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
205,436 |
|
- |
|
| Elston George |
Chief Financial Officer |
• – – |
2025-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,834 |
75,550 |
|
- |
|
| Duker Jay S. |
President and CEO |
• • – |
2025-02-09 |
4 |
D |
$6.50 |
$13,347 |
D/D |
(2,055) |
77,651 |
|
- |
|
| Duker Jay S. |
President and CEO |
• • – |
2025-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,000 |
79,706 |
|
- |
|
| Duker Jay S. |
President and CEO |
• • – |
2025-01-06 |
4 |
D |
$8.68 |
$53,017 |
D/D |
(6,108) |
72,706 |
|
- |
|
| Duker Jay S. |
President and CEO |
• • – |
2025-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,794 |
78,814 |
|
- |
|
| Lurker Nancy |
|
– • – |
2025-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
75,134 |
185,436 |
|
- |
|
| Elston George |
Chief Financial Officer |
• – – |
2025-01-06 |
4 |
D |
$8.68 |
$41,733 |
D/D |
(4,808) |
68,566 |
|
- |
|
| Elston George |
Chief Financial Officer |
• – – |
2025-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,285 |
73,374 |
|
- |
|
| Duker Jay S. |
President and CEO |
• • – |
2025-01-05 |
4 |
D |
$8.26 |
$82,658 |
D/D |
(10,007) |
58,020 |
|
- |
|
265 Records found
|
|
Page 1 of 11 |
|
|
